Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice (vol 20, pg 862, 2018)

Blancas I.; Fontanillas M.; Conde V.; Lao J.; Martinez E.; Sotelo M. J.; Jaen A.; Bayo J. L.; Carabantes F.; Illarramendi J. J.; Gordon M. M.; Cruz J.; Garcia-Palomo A.; Mendiola C.; Perez-Ruiz E.; Bofill J. S.; Baena-Canada J. M.; Janez N. M.; Esquerdo G.; Ruiz-Borrego M.

首页> 外文期刊>Clinical & translational oncology : >Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice (vol 20, pg 862, 2018)

【24h】

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice (vol 20, pg 862, 2018)

机译：氟斯特提患者在常规临床实践中治疗内分泌抗性晚期乳腺癌后期妇女的治疗（Vol 20，PG 862,2018）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

A sentence under Results' heading in the Abstract section was published incorrectly. The correct sentence should read as follows:

机译：在抽象部分标题的结果下的句子被错误地发布。正确的句子应该如下阅读：

著录项

来源
《Clinical & translational oncology :》 |2018年第12期|共2页
作者
Blancas I.; Fontanillas M.; Conde V.; Lao J.; Martinez E.; Sotelo M. J.; Jaen A.; Bayo J. L.; Carabantes F.; Illarramendi J. J.; Gordon M. M.; Cruz J.; Garcia-Palomo A.; Mendiola C.; Perez-Ruiz E.; Bofill J. S.; Baena-Canada J. M.; Janez N. M.; Esquerdo G.; Ruiz-Borrego M.;
展开▼
作者单位

Hosp Univ Clin San Cecilio Complejo Hosp Univ C Dr Oloriz 16 Granada 18012 Spain;

Hosp Clin Barcelona Illarroel 170 Barcelona 08036 Spain;

Hosp Univ Virgen de las Nieves Ave Fuerzas Armadas S-N Granada 18014 Spain;

Hosp Univ Miguel Servet Paseo Isabel Catolica 1-3 Zaragoza 50009 Spain;

Hosp Prov Castellon Ave Dr Clara 19 Castellon de La Plana 12002 Spain;

Hosp Univ Clin San Carlos C Prof Martin Lagos S-N Madrid 28040 Spain;

Hosp Jaen Avda Ejercito Espanol 10 Jaen 23007 Spain;

Hosp Juan Ramon Jimenez Ronda Exterior Norte S-N Huelva 21005 Spain;

Hosp Univ Carlos Haya Ave Carlos Haya S-N Malaga 29010 Spain;

Complejo Univ Hosp Navarra Calle Irunlarrea 3 Pamplona 31008 Spain;

Hosp Jerez Ronda Circunvalac S-N Cadiz 11407 Spain;

Hosp Univ Canarias Carretera Ofra S-N Santa Cruz De Tenerife 38320 Spain;

Complejo Univ Asistencial Leon C Altos Nava S-N Leon Spain;

Hosp Univ 12 Octubre Ave Cordoba S-N Madrid 28041 Spain;

Hosp Costa Sol Autovia A-7 Km 187 Marbella 29603 Spain;

Hosp Nuestra Senora De Valme Ave Bellavista S-N Seville 41014 Spain;

Hosp Univ Puerta del Mar Ave Ana Viya 21 Cadiz 11009 Spain;

Hosp Ramon &

Cajal Ctra Colmenar Viejo Km 9 100 E-28034 Madrid Spain;

Clin Benidorm Ave Alfonso Puchades Benidorm 03501 Spain;

Hosp Univ Virgen del Rocio Ave Manuel Siurot S-N Seville 41013 Spain;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 弗隆和氨鲁米特治疗绝经后妇女晚期乳腺癌临床观察 [J] . 刘晓晴, 宋三泰, 江泽飞, 中德临床肿瘤学杂志（英文版） . 2005,第006期
2. Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice (vol 20, pg 862, 2018) [J] . Blancas I., Fontanillas M., Conde V., Clinical & translational oncology : . 2018,第12期

机译：氟斯特提患者在常规临床实践中治疗内分泌抗性晚期乳腺癌后期妇女的治疗（Vol 20，PG 862,2018）
3. Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (vol 171, pg 535, 2018) [J] . Wang Jiayu, Xu Binghe, Wang Wenna, Breast cancer research and treatment. . 2019,第2期

机译：氟斯特语在绝经后患者患有激素受体阳性晚期乳腺癌患者的疗效和安全性：系统文献综述和荟萃分析（Vol 171，PG 535,2018）
4. Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, doubleblind, placebo-controlled, phase 3 trial (vol 19, pg 87, 2018) [J] . Di Leo A., Johnston S., Lee K. S. The lancet oncology . 2018,第3期

机译：Buparlisib Plus在绝经后妇女的氟斯特语患有激素受体阳性，Her2阴性，晚期乳腺癌进展（Belle-3）：A随机，双卷麟，安慰剂控制，第3阶段试验（Vol 19，PG 87 ，2018）
5. Study on the Efficacy Evaluation of Oral Sequential Tamoxifen in Postmenopausal Women with Hormone-dependent Breast Cancer [C] . Na Li, Yahua Sun, Sheng Zhao, International Conference on Life Sciences, Medicine, and Health . 2018

机译：激素依赖性乳腺癌后代妇女口腔序列儿毒素疗效评价研究
6. The effects of soy protein and probiotics on isoflavone and hormone metabolism in postmenopausal breast cancer survivors and women with no cancer history. [D] . Nettleton, Jennifer Ann. 2003

机译：大豆蛋白和益生菌对绝经后乳腺癌幸存者和无癌症史女性的异黄酮和激素代谢的影响。
7. Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant hormone receptor-positive human epidermal growth factor receptor 2-negative advanced breast cancer [O] . William J Gradishar 2016

机译：绝经后妇女患有内分泌抵抗激素受体阳性人表皮生长因子受体2阴性的晚期乳腺癌的社区肿瘤学家的治疗挑战
8. Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice [O] . I. Blancas, M. Fontanillas, V. Conde, 2018

机译：矫正：氟斯特提患者在常规临床实践中治疗内分泌晚期乳腺癌后期妇女的治疗

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice (vol 20, pg 862, 2018)

摘要

著录项

相似文献

相关主题

期刊订阅